Tufts professor helps lead effort to reduce airplane emissions see FEATURES / PAGE 4
WOMEN’S BASKETBALL
Jumbos look for road win against WPI off Emerson victory
Amazon brings The New York Times’ ‘Modern Love’ podcast to small screen see ARTS&LIVING / PAGE 5
SEE SPORTS / BACK PAGE
THE
INDEPENDENT
STUDENT
N E W S PA P E R
OF
TUFTS
UNIVERSITY
E S T. 1 9 8 0
T HE T UFTS DAILY
VOLUME LXXVIII, ISSUE 60
Friday, December 6, 2019
MEDFORD/SOMERVILLE, MASS.
Responding to Stern report findings, Tufts removes Sackler name, establishes endowment
tuftsdaily.com
Report reveals loose conflictof-interest policies, deference to donors benefitted Purdue Pharma
ALEXANDER THOMPSON / THE TUFTS DAILY ARCHIVES
The building formerly known as the Arthur M. Sackler Center for Medical Education is pictured on June 19.
Ballou Hall is pictured on April 20, 2018.
by Austin Clementi
by Austin Clementi and Caleb Symons
Executive News Editor
In the wake of former U.S. Attorney for Massachusetts Donald K. Stern and Attorney Sandy Remz’s report on Tufts’ relationship to the Sackler family and Purdue Pharma, Tufts has decided to remove the Sackler name from its campuses, effective immediately, in addition to the establishment of a $3 million endowment focused on substance abuse and addiction treatment and prevention. The decision comes after months of lobbying and actions by student activists of varying levels and public statements by community members and professors calling on Tufts to remove the name from the school. “We are grateful for the students, faculty and alumni we met with who made it clear that the Sackler name now runs counter to the mission of the medical school, has had a negative impact on their studies and professional careers and contradicts the purpose for which the gifts were initially given: to advance public health and research,” Peter Dolan, the chairman of the Board of Trustees, said. According to a press release published
Please recycle this newspaper
PM Rain 36 / 24
/thetuftsdaily
on TuftsNow, five entities will change their names. Notably, the Sackler School of Biomedical Sciences will become the Tufts Graduate School of Biomedical Sciences and the Arthur M. Sackler Center for Medical Education, the central building in the Health Sciences campus, will become the Tufts Center for Medical Education. The Sackler name will also be removed from buildings and programs formerly known as the Sackler Laboratory for the Convergence of Biomedical, Physical and Engineering Sciences; the Sackler Families Fund for Collaborative Cancer Biology Research; and the Richard Sackler Endowed Research Fund. Members of the Sackler family as well as a lawyer for members of the family were disappointed with the decision to remove the name. “Arthur had nothing to do with OxyContin. The man has been dead for 32 years,” Jillian Sackler, Arthur Sackler’s widow, said in a statement. “He did not profit from OxyContin, and none of his philanthropic gifts were in any way connected to opioids or to deceptive medical marketing – which he see SACKLER, page 2
For breaking news, our content archive and exclusive content, visit tuftsdaily.com @tuftsdaily
tuftsdaily
tuftsdaily
RACHEL HARTMAN / THE TUFTS DAILY ARCHIVES
Executive News Editor and Executive Investigative Editor
An independent report released Thursday indicates that a systemic lack of oversight at the Tufts University School of Medicine (TUSM) and a culture of appeasing donors allowed the Sackler family and its controversial pharmaceutical company, Purdue Pharma, to buy influence and bolster their reputation long after their central role in the opioid crisis came to light. The report, written by former U.S. Attorney for Massachusetts Donald K. Stern and Attorney Sanford F. Remz of Yurko, Salvesen & Remz, P.C., found no clear violations of Tufts’ conflict-of-interest policies nor evidence that Purdue or the Sacklers had a significant impact on the university’s academic program. Nonetheless, Stern and Remz identified several ways in which the Sackler family and Purdue were able to exercise influence on the university, including the appointment of a Purdue official to a faculty position and an aversion to criticism of the company’s role in the opioid crisis. Purdue has been implicated in the opioid crisis for manufacturing and distributing the drug OxyContin, one of the major drugs responsible for the crisis. In January, Massachusetts Attorney General Maura
Contact Us P.O. Box 53018, Medford, MA 02155 daily@tuftsdaily.com
Healey presented evidence from the Commonwealth’s lawsuit against Purdue alleging the company deceived medical professionals into overprescribing opioid painkillers and exploited the resulting addiction epidemic for its own corporate gain. University President Anthony Monaco tapped Stern in February to review the university’s relationship with the Sackler family and Purdue amid growing pressure from the Tufts community.
Tufts’ financial ties to Purdue and the Sackler family That relationship began in 1980, when Arthur, Mortimer and Raymond Sackler made a significant contribution to Tufts in exchange for the university attaching the Sackler name to its new School of Graduate Biomedical Sciences. Three years later, Arthur Sackler entered a similar agreement to secure naming rights for the TUSM building. The Sackler-owned pharmaceutical company, Purdue Pharma, established a financial relationship with Tufts in the following decades. In 1999, Purdue funded the new Pain Research, Education and Policy (PREP) program at TUSM, contributing over $2 million to the program over the next 10 years.
NEWS............................................1 FEATURES.................................4 ARTS & LIVING.......................5
see REPORT, page 2
FUN & GAMES......................... 7 SPORTS............................ BACK